WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 13-Jul-2018 (data as of 09-Jul-2018)
Next overall update Winter 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 33  33  33  33  32  27  24  21 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for San Marino)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
 
Mumps
ChartChart
  11 
Pertussis
ChartChart
  13 
Polio*
ChartChart
 
Rubella
ChartChart
  11 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for San Marino)
Vaccine year result method % card seen                                                
BCG         
DTP1          94  78  77  82  72  97 
DTP3          85  66  76  80  69  96 
DTP4          79  77  79  75 
IPV1          94  78  77  82 
HepB_BD         
HepB3          77  66  75  80  69  94 
Hib3          77  65  79  69  92 
JapEnc         
MCV1          85  62  53  57  74  74 
MCV2          81  36  82  76  77 
MenA          18 
PCV1          52  38 
PCV2          45  33 
PCV3          44  13 
Pol3          85  66  76  80  96 
Rota1         
RotaC         
RCV1          85  62  53  57  74 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for San Marino)
DTP1
ChartChart
  77  77  82  72  97  99 
DTP3
  76  76  80  69  96  99 
HepB3
  75  75  80  69  94 
HepB_BD
ChartChart
 
Hib3
ChartChart
  75  75  79  69  92 
MCV1
  53  53  57  74  74 
MCV2
  82  82  76  77 
PCV3
 
Pol3
  76  76  80  69  96  99 
RCV1
  53  53  57  74  74 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
CHOLERA Yes travellers
DTaP 15 years; Yes
DTaPHibHepBIPV 3, 5, 11 months; Yes
DTaPHibHepIPV 3, 5, 11 months; Yes
DTaPIPV 5 years; Yes
HepA_Adult Yes risk categories, outbreaks, travellers
HepA_Pediatric Yes risk categories, outbreaks, travellers
HepB_Pediatric birth; Yes risk categories, outbreaks, travellers
HIB Yes risk categories
HPV 11-14 years; +6 months Yes females only
Influenza_Adult Yes elderly, adults with chronic illness, health care workers, residents living in long-term care facilities
Influenza_Pediatric Yes children with chronic illness
IPV Yes travellers
JE_Inactd Yes travellers (given in Italy)
MenACWY-135 conj 13 months; 13 years; Yes and travellers
MenB 4, 6, 7, 13-14 months; Yes
MenC_conj 13 months;
MMR 15 months; 10 years; Yes
Pneumo_conj 3, 5, months; 11 years; Yes risk categories
Pneumo_ps Yes risk categories
Rabies Yes travellers
Rubella Yes risk groups
Tdap Yes adults every 10 years
TT Yes every 10 years to individuals that refuse TdaP
Typhoid Yes travellers
Varicella 15 months; 10 years; Yes
YF Yes travellers (given in Italy)

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  No  No  No  No 
What years does the MYP cover? number 2017-2020  2017-2019           
Nº of districts with microplans that include activities to raise immunization coverage number            

System performance

Total Nº districts in country number      
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes    No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes    No       

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100      100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.